BSE issues corrected in-principle approval for 16,21,000 convertible warrants to promoters

Krsnaa Diagnostics has received a corrected in-principle approval letter from BSE for the issue of 16,21,000 convertible warrants to the Promoter and Promoter Group.

Fri 9 Oct 2026

Warrants to be issued

16,21,000 convertible warrants to the Promoter and Promoter Group

Issue price

Rs. 566/- each

Conversion & face value

convertible into 16,21,000 equity shares; face value Rs. 5/- each

Corrected in-principle approval received

Krsnaa Diagnostics has informed BSE and NSE that it has received a corrected in-principle approval letter from BSE Limited (letter no. LOD/PREF/PB/FIP/908/2026-27 dated October 07, 2026) for the issue of 16,21,000 convertible warrants on a preferential basis to the Promoter and Promoter Group of the Company. The company said the corrected letter rectifies factual errors in the earlier letter, and that this follows its earlier intimation dated October 08, 2026.

What the approval covers

• Issue of 16,21,000 convertible warrants on a preferential basis to the Promoter and Promoter Group.
• The warrants are convertible into 16,21,000 equity shares of face value Rs. 5/- each.
• Issue price: Rs. 566/- each.

Conditions attached by BSE

• The in-principle approval should not be construed as approval for listing of the securities; the company must separately comply with the listing requirements.
• The company must obtain an undertaking from the allottee(s) confirming that they shall not do intra-day trading in the scrip of the company, or any sale of the scrip, till the allotment date.
• The responsibility to verify this undertaking and ensure compliance rests solely on the issuer company, and any non-compliance observed after the undertaking and verification may impact the listing of such shares.
• On allotment, the company must make a listing application without delay, with applicable fees, and within twenty days from the date of allotment.
• BSE reserves the right to withdraw the in-principle approval at any stage if the information submitted is found to be incomplete, incorrect, misleading or false, or if it contravenes any rules, bye-laws and regulations.

What a convertible warrant means here

A convertible warrant is a right to be allotted an equity share at a later date, against payment of the issue price. Here the warrants are being issued to the promoter and promoter group, so the shares that follow on conversion would go to them. On conversion, the number of equity shares of the company would increase by 16,21,000 shares of face value Rs. 5/- each.

How to read this update

• This is the approval stage of the preferential issue of warrants. The BSE letter sets out steps that apply before allotment (the allottee undertaking) and after allotment (the listing application within twenty days).
• The company's earlier intimation, dated October 08, 2026, was about receipt of in-principle approval from BSE Limited and National Stock Exchange of India Limited for the same issue of 16,21,000 warrants convertible into 16,21,000 equity shares of face value Rs. 5/- each at an issue price of Rs. 566/- each.
• The present update is a corrected in-principle approval letter from BSE Limited, issued to rectify factual errors in the earlier letter.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.